Avantax Advisory Services Inc. grew its position in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 144.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 65,151 shares of the real estate investment trust's stock after acquiring an additional 38,462 shares during the quarter. Avantax Advisory Services Inc.'s holdings in Healthpeak Properties were worth $1,321,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of DOC. Avior Wealth Management LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $37,000. Groupama Asset Managment bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $37,000. Wiser Advisor Group LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $42,000. Continuum Advisory LLC bought a new stake in shares of Healthpeak Properties in the 3rd quarter worth approximately $44,000. Finally, AdvisorNet Financial Inc lifted its position in shares of Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust's stock worth $44,000 after acquiring an additional 563 shares during the period. Institutional investors own 93.57% of the company's stock.
Analyst Upgrades and Downgrades
DOC has been the subject of a number of research reports. Scotiabank reduced their price objective on Healthpeak Properties from $24.00 to $23.00 and set a "sector outperform" rating for the company in a research report on Friday, February 28th. Wells Fargo & Company cut their target price on Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Morgan Stanley upgraded Healthpeak Properties from an "equal weight" rating to an "overweight" rating and set a $25.00 target price for the company in a research report on Wednesday, January 15th. Robert W. Baird cut their target price on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Tuesday, February 11th. Finally, Wedbush cut their target price on Healthpeak Properties from $27.00 to $24.00 and set an "outperform" rating for the company in a research report on Friday, February 14th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $23.92.
View Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Price Performance
DOC stock traded down $0.34 during midday trading on Friday, reaching $20.02. 7,429,661 shares of the company's stock traded hands, compared to its average volume of 4,638,445. The company has a 50-day simple moving average of $20.24 and a two-hundred day simple moving average of $21.17. Healthpeak Properties, Inc. has a 1-year low of $17.45 and a 1-year high of $23.26. The company has a market cap of $14.00 billion, a price-to-earnings ratio of 57.19, a PEG ratio of 2.17 and a beta of 1.14. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.
Healthpeak Properties Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Investors of record on Friday, February 14th were issued a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a yield of 6.10%. This is a boost from Healthpeak Properties's previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties's dividend payout ratio (DPR) is currently 348.57%.
Healthpeak Properties Company Profile
(
Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.